WEBVTT

1
00:00:00.000 --> 00:00:02.599
(gentle music)

2
00:00:03.519 --> 00:00:04.360
<v ->[Narrator] Health equity</v>

3
00:00:04.360 --> 00:00:06.800
is no longer just a human-rights issue.

4
00:00:06.800 --> 00:00:10.320
Today, it's become a business imperative.

5
00:00:10.320 --> 00:00:13.480
Growing pressure from
investors, civil society,

6
00:00:13.480 --> 00:00:17.360
healthcare providers, and patients 
is inspiring public- and

7
00:00:17.360 --> 00:00:21.079
private-sector organizations
to address inequities.

8
00:00:22.559 --> 00:00:25.280
(dramatic music)

9
00:00:29.239 --> 00:00:32.079
<v ->Drugs are available in
high-income countries,</v>

10
00:00:32.079 --> 00:00:34.519
drugs that save lives.

11
00:00:34.519 --> 00:00:37.079
Those same drugs are
not available or they're

12
00:00:37.079 --> 00:00:40.760
too expensive in low- and
middle-income countries,

13
00:00:40.760 --> 00:00:42.400
and so people are dying

14
00:00:42.400 --> 00:00:45.639
simply because they do not have access.

15
00:00:45.639 --> 00:00:50.519
The Medicines Patent Pool was
set up in 2010 by Unitaid.

16
00:00:50.519 --> 00:00:54.599
So, at the time, there were
new patented drugs for HIV,

17
00:00:54.599 --> 00:00:56.239
but they were too expensive

18
00:00:56.239 --> 00:00:58.880
for most low- and middle-income countries,

19
00:00:58.880 --> 00:01:00.320
and the concept was

20
00:01:00.320 --> 00:01:03.760
that if we could persuade
pharmaceutical companies

21
00:01:03.760 --> 00:01:06.920
to give us licenses on
their patented drugs,

22
00:01:06.920 --> 00:01:10.480
we could sublicense it
to generic manufacturers

23
00:01:10.480 --> 00:01:14.280
who could produce affordable
but high-quality versions.

24
00:01:14.280 --> 00:01:17.559
<v ->Then this mandate
evolved in TB and Hep-C</v>

25
00:01:17.559 --> 00:01:19.840
and other infectious disease spaces.

26
00:01:21.679 --> 00:01:24.559
Once COVID showed up, what happened is

27
00:01:24.559 --> 00:01:27.960
that the world recognized the mechanism

28
00:01:27.960 --> 00:01:31.880
of voluntary licensing through
MPP as an excellent way

29
00:01:31.880 --> 00:01:35.039
to have global access to the medicines.

30
00:01:35.039 --> 00:01:38.320
<v ->So in 2021, this was set up</v>

31
00:01:38.320 --> 00:01:42.559
as the mRNA Technology Transfer Programme,

32
00:01:42.559 --> 00:01:47.079
and the idea was to establish
vaccine manufacturing

33
00:01:47.079 --> 00:01:49.840
in a way that was sustainable

34
00:01:49.840 --> 00:01:54.320
to make sure that the companies
that receive the technology

35
00:01:54.320 --> 00:01:57.480
will be in a position to
respond to the next pandemic.

36
00:01:58.760 --> 00:02:00.920
The interest is in the platform

37
00:02:00.920 --> 00:02:03.559
that can then be used for other diseases.

38
00:02:06.280 --> 00:02:09.880
The key concept behind
this is empowerment,

39
00:02:09.880 --> 00:02:14.880
so what MPP are doing
is supporting the growth

40
00:02:15.280 --> 00:02:19.320
of this capability in low-
and middle-income countries.

41
00:02:20.519 --> 00:02:22.320
This program is different

42
00:02:22.320 --> 00:02:26.280
to anything really
that's been tried before.

43
00:02:26.760 --> 00:02:29.320
<v ->[Narrator] The
Medicines Patent Pool and partners</v>

44
00:02:29.320 --> 00:02:31.920
established a Technology
Transfer Programme

45
00:02:31.920 --> 00:02:34.639
for mRNA vaccines in South Africa.

46
00:02:37.880 --> 00:02:39.480
<v ->You have to remember
that at the beginning</v>

47
00:02:39.480 --> 00:02:43.840
it was just a concept and
it needed a lot of shaping,

48
00:02:43.840 --> 00:02:47.760
and BCG were extremely
helpful in doing that.

49
00:02:47.760 --> 00:02:50.000
BCG stepped into the gap

50
00:02:50.000 --> 00:02:53.440
and really provided the project management

51
00:02:53.440 --> 00:02:55.679
and a lot of the legs, if you like,

52
00:02:55.679 --> 00:02:57.519
to really get this off the ground.

53
00:02:57.519 --> 00:02:59.559
<v ->Once it comes to put a structure</v>

54
00:02:59.559 --> 00:03:01.880
and align stakeholders around the table

55
00:03:01.880 --> 00:03:03.719
and make them speak at one voice,

56
00:03:03.719 --> 00:03:06.920
this is one of the things I think BCG did

57
00:03:06.920 --> 00:03:09.880
that was strongly
contributing to the success

58
00:03:09.880 --> 00:03:13.679
of the mRNA program from scratch.

59
00:03:13.679 --> 00:03:15.360
<v ->[Narrator] The program
successfully developed</v>

60
00:03:15.360 --> 00:03:18.800
the first mRNA vaccine
candidate, AfriVac 2121.

61
00:03:20.239 --> 00:03:23.239
To date, all but one of
the 15 program partners

62
00:03:23.239 --> 00:03:24.760
received the introduction training

63
00:03:24.760 --> 00:03:28.039
for developing the mRNA
platform at country level.

64
00:03:29.119 --> 00:03:33.519
<v ->What COVID has done is
really focus people's attention</v>

65
00:03:33.519 --> 00:03:38.480
on the critical nature
of health inequalities

66
00:03:38.480 --> 00:03:40.960
and making sure that we address them.

67
00:03:40.960 --> 00:03:45.920
That means that there need to
be a lot more licenses given

68
00:03:45.920 --> 00:03:49.639
to us, in our opinion,
to ensure health equity.

69
00:03:52.039 --> 00:03:55.039
<v ->This, of course,
increased the visibility</v>

70
00:03:55.039 --> 00:03:56.320
of MPP in the world,

71
00:03:56.320 --> 00:03:59.599
and our mandate would then expand it,

72
00:03:59.599 --> 00:04:02.440
including the NCD space.

73
00:04:04.000 --> 00:04:09.000
<v ->Licensing too often has been
thought of as a PR activity</v>

74
00:04:09.559 --> 00:04:12.119
or a CSR activity,

75
00:04:12.119 --> 00:04:16.639
and so we're delighted
to be partnering with BCG

76
00:04:16.639 --> 00:04:21.639
to look at how we can
quantify the dollar value

77
00:04:21.760 --> 00:04:23.400
of doing licensing.

78
00:04:23.400 --> 00:04:25.480
If we can do this successfully,

79
00:04:25.480 --> 00:04:29.719
this could completely change
the mindset in industry,

80
00:04:29.719 --> 00:04:33.400
and that could revolutionize access.

81
00:04:33.400 --> 00:04:36.159
(dramatic music)